We compared HIF1A loss and HIF2A gain tumours to diploid human ccRCCs (Fig. 7n) and also took advantage of the wide distribution of mRNA expression levels of HIF2A to compare tumours in the top (Q4) and bottom (Q1) quartiles of HIF2A mRNA abundance. The gene discussed is EPAS1; the disease is neoplasm.